The first part of this thesis evaluates the proportion of germline APC and MUTYH pathogenic variants in colorectal polyposis patients and subsequently identifies the substantial proportion... Show moreThe first part of this thesis evaluates the proportion of germline APC and MUTYH pathogenic variants in colorectal polyposis patients and subsequently identifies the substantial proportion polyposis patients remaining unexplained. Part II of this thesis elucidates the significance of APC mosaicism in these unexplained polyposis patients. Analysis of more than 400 patients resulted in a suggestion for both testing and surveillance guidelines. Moreover, chapter 4 describes the interesting finding of multiple APC mosaicism cases in one family with the family members having distinct mosaic patterns and phenotypes. The last part of this thesis assesses another explanation for the development of colorectal adenomatous polyps, namely the presence of pks+ E. coli and colibactin-associated mutational signatures. In this part we describe the common c.835-8A>G APC splice variant as fitting the mutational signature caused by colibactin, which is produced by pks+ E. coli. Moreover, we examine this mutational signature and fecal pks genes in a random selection of our cohort. Show less
BACKGROUND & AIMS: Patients with multiple recurrent Clostridioides difficile infection (rCDI) have a disturbed gut microbiota that can be restored by fecal microbiota trans-plantation (FMT).... Show moreBACKGROUND & AIMS: Patients with multiple recurrent Clostridioides difficile infection (rCDI) have a disturbed gut microbiota that can be restored by fecal microbiota trans-plantation (FMT). Despite extensive screening, healthy feces donors may carry bacteria in their intestinal tract that could have long-term health effects, such as potentially procarci-nogenic polyketide synthase-positive (pks+) Escherichia coli. Here, we aim to determine whether the pks abundance and persistence of pks+ E coli is influenced by pks status of the donor feces. METHODS: In a cohort of 49 patients with rCDI treated with FMT and matching donor samples-the largest cohort of its kind, to our knowledge-we retrospectively screened fecal metagenomes for pks+ E coli and compared the presence of pks in patients before and after treatment and to their respective donors. RESULTS: The pks island was more prevalent (P = .026) and abundant (P < .001) in patients with rCDI (pre-FMT, 27 of 49 [55%]; median, 0.46 reads per kilobase per million [RPKM] pks) than in healthy donors (3 of 8 donors [37.5%], 11 of 38 samples [29%]; median, 0.01 RPKM pks). The pks status of patients post-FMT depended on the pks status of the donor suspension with which the patient was treated (P = .046). Particularly, persistence (8 of 9 cases) or clearance (13 of 18) of pks+ E coli in pks+ patients was correlated to pks in the donor (P = .004). CONCLUSIONS: We conclude that FMT contrib-utes to pks+ E coli persistence or eradication in patients with rCDI but that donor-to-patient transmission of pks+ E coli is unlikely. Show less
